Results 11 to 20 of about 108,963 (268)
Familial Parkinson’s Disease/Parkinsonism [PDF]
Parkinson's disease (PD) is the second most common neurodegenerative disorder characterized by parkinsonism (bradykinesia, resting tremor, rigidity, and postural instability) with good response to L-dopa. Although the majority of PD patients are sporadic, it is now clear that genetic factors contribute to the pathogenesis of PD.
Hiroyuki Tomiyama +3 more
openaire +2 more sources
Clinical neurophysiology of Parkinson’s disease and parkinsonism [PDF]
This review is part of the series on the clinical neurophysiology of movement disorders. It focuses on Parkinson's disease and parkinsonism. The topics covered include the pathophysiology of tremor, rigidity and bradykinesia, balance and gait disturbance and myoclonus in Parkinson's disease.
Chen, Robert +16 more
openaire +4 more sources
Exploring the multifaceted neuroprotective actions of gallic acid: a review
Much attention has been recently given to the effect of diet compounds on physical and mental health. Gallic acid is a phenolic compound with antioxidant activity.
Sahreh Shabani +2 more
doaj +1 more source
Background First-line rehabilitative strategies to improve motor deficits are based on functional training (physical or occupational therapy), which has been demonstrated to facilitate neural reorganisation.
Zhao-hui Jin +17 more
doaj +1 more source
Stimulator of interferon genes (STING) is activated after detection of cytoplasmic dsDNA by cGAS (cyclic GMP-AMP synthase) as part of the innate immunity defence against viral pathogens. STING binds TANK-binding kinase 1 (TBK1).
Eva M Szego +5 more
doaj +1 more source
Parkinson’s Disease and Parkinsonism
Parkinson’s disease (PD), or paralysis agitans is a common neurodegenerative and heterogeneous disorder. Parkinson’s symptoms include bradykinesia, rigidity and tremor. PD is pathologically characterized by the loss of dopaminergic neurons of the substantia nigra. Treatment involves pharmacologic and nonpharmacologic approaches.
Tuba Erdoğan Soyukibar, Dilaver Kaya
openaire +1 more source
Ambroxol therapy for Parkinson’s disease: Systematic literature review [PDF]
Parkinson’s disease (PD) is the second most common neurodegenerative disease. The accumulation of α-synuclein protein in the basal ganglia is the underlying pathogenesis of PD. Genetic abnormalities are one of the predisposing factors for PD.
Virgi Mayang Maharani +3 more
doaj +1 more source
Efectividad de tres métodos de estimación de edad dental en personas adultas vivas - Región Huánuco
Objetivo. Determinar la efectividad de tres métodos de estimación de edad dental en personas adultas vivas de la región de Huánuco. Métodos. Fue una investigación aplicada de diseño transversal, a partir de un estudio correlacional, comparativo, de ...
Ronald Christian Solís Adrianzèn
doaj +1 more source
Influencia de la microbiota intestinal en la enfermedad de Parkinson. Revisión
El objetivo del presente estudio es analizar el papel de la microbiota intestinal en la progresión de la enfermedad de Parkinson, realizando una revisión bibliográfca.
Alejandra Belen Maldonado Gomez +3 more
doaj +1 more source
Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?
The role of phagocytosis in the neuroprotective function of microglia has been appreciated for a long time, but only more recently a dysregulation of this process has been recognized in Parkinson’s disease (PD).
Elzbieta Janda, Laura Boi, Anna R. Carta
doaj +1 more source

